Real-world effectiveness of highly purified cannabidiol in epilepsy associated with 15q11.2-q13.1 duplication and deletion syndromes: A multicenter study
Emanuele Cerulli Irelli(Sapienza University of Rome), Alessandro Orsini, Irene Bagnasco(Ospedale Martini), Georgia Ramantani(University Children's Hospital Zurich), Adolfo Mazzeo(Sapienza University of Rome), Marco Perulli(Community Options (United States)), Antonietta Coppola(University of Naples Federico II), Carlo Di Bonaventura(Sapienza University of Rome), Francesca F Operto, Alberto Danieli, Domenica Battaglia, Paolo Bonanni, Susanna Negrin(IRCCS Eugenio Medea), Pasquale Striano, Erica Cognolato(Community Options (United States))
Cited by 0
Related Papers
Recurrent Rearrangements of Chromosome 1q21.1 and Variable Pediatric Phenotypes
|New England Journal of Medicine|2008|811
Doing without valproate in women of childbearing potential with idiopathic generalized epilepsy: Implications on seizure outcome
|Epilepsia|2019|64
Adjunctive Brivaracetam in Focal Epilepsy: Real-World Evidence from the BRIVAracetam add-on First Italian netwoRk STudy (BRIVAFIRST)
|CNS Drugs|2021|56
Perampanel as precision therapy in rare genetic epilepsies
|Epilepsia|2023|43